Literature DB >> 10415848

Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle.

P J Chiao1, K K Hunt, A M Grau, A Abramian, J Fleming, W Zhang, T Breslin, J L Abbruzzese, D B Evans.   

Abstract

The tumor suppressor gene deleted in pancreatic cancer locus 4 (Smad4/DPC4) is inactivated in about 50% of pancreatic adenocarcinomas. The role of DPC4 in the transforming growth factor-beta (TGF-beta) receptor-mediated signal transduction cascade in human pancreatic, colon, and breast carcinoma cell lines has been investigated by a number of laboratories. The results demonstrate that Smad4/DPC4 protein functions as a key transcription factor required in regulation of TGF-beta inducible gene expression and subsequent growth inhibition. Many transcription regulators that are involved in cell growth, differentiation, and oncogenesis have been identified and cloned. Yet paradoxically, it is much more difficult to identify the important downstream target genes responsible for the biological effects elicited by these transcription factors. Although numerous attempts have been made and different approaches have been used to identify the target genes, only limited success has been achieved. Our data show that p21waf1 is one of the Smad4/DPC4-regulated downstream target genes and suggest that overexpression of the Smad4/DPC4 gene can bypass TGF-beta receptor activation and reestablish one of the key regulatory controls of cell proliferation. Identification of the Smad-regulated downstream target genes responsible for diverse biological processes that they control will extend our understanding of the mechanism for cell cycle regulation and cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10415848     DOI: 10.1111/j.1749-6632.1999.tb09507.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

1.  Resveratrol selectively induces DNA Damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma.

Authors:  Alpna Tyagi; Mallikarjuna Gu; Takenori Takahata; Barbara Frederick; Chapla Agarwal; Sunitha Siriwardana; Rajesh Agarwal; Robert A Sclafani
Journal:  Clin Cancer Res       Date:  2011-06-24       Impact factor: 12.531

2.  Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.

Authors:  Zhan Hua; Yuan-Chun Zhang; Xiao-Ming Hu; Zhen-Geng Jia
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

3.  Smad2 and Smad6 as predictors of overall survival in oral squamous cell carcinoma patients.

Authors:  Flavia R R Mangone; Fernando Walder; Simone Maistro; Fátima S Pasini; Carlos N Lehn; Marcos B Carvalho; M Mitzi Brentani; Igor Snitcovsky; Miriam H H Federico
Journal:  Mol Cancer       Date:  2010-05-12       Impact factor: 27.401

4.  Identification of actively translated mRNA transcripts in a rat model of early-stage colon carcinogenesis.

Authors:  Laurie A Davidson; Naisyin Wang; Ivan Ivanov; Jennifer Goldsby; Joanne R Lupton; Robert S Chapkin
Journal:  Cancer Prev Res (Phila)       Date:  2009-10-20

5.  Growth inhibition induced by transforming growth factor-beta1 in human oral squamous cell carcinoma.

Authors:  Xiumei Wang; Wenjing Sun; Jing Bai; Linlin Ma; Yang Yu; Jingshu Geng; Jiping Qi; Zhongcheng Shi; Songbin Fu
Journal:  Mol Biol Rep       Date:  2008-04-17       Impact factor: 2.316

6.  LncRNA MTX2-6 Suppresses Cell Proliferation by Acting as ceRNA of miR-574-5p to Accumulate SMAD4 in Esophageal Squamous Cell Carcinoma.

Authors:  Jie Li; Xu Han; Yan Gu; Jixiang Wu; Jianxiang Song; Zhan Shi; Huiwen Chang; Ming Liu; Yajun Zhang
Journal:  Front Cell Dev Biol       Date:  2021-03-23

7.  Ginkgolic Acid, a SUMO-1 Inhibitor, Inhibits the Progression of Oral Squamous Cell Carcinoma by Alleviating SUMOylation of SMAD4.

Authors:  Ke Liu; Xinhuan Wang; Duo Li; Dongyang Xu; Dezhi Li; Zhiyong Lv; Dan Zhao; Wen-Feng Chu; Xiao-Feng Wang
Journal:  Mol Ther Oncolytics       Date:  2019-12-14       Impact factor: 7.200

8.  SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization.

Authors:  Chao Dai; Jonathan P Rennhack; Taylor E Arnoff; Maneesha Thaker; Scott T Younger; John G Doench; August Yue Huang; Annan Yang; Andrew J Aguirre; Belinda Wang; Evan Mun; Joyce T O'Connell; Ying Huang; Katherine Labella; Jessica A Talamas; Ji Li; Nina Ilic; Justin Hwang; Andrew L Hong; Andrew O Giacomelli; Ole Gjoerup; David E Root; William C Hahn
Journal:  Cell Rep       Date:  2021-07-27       Impact factor: 9.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.